Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Batch documentation: see Lab Reports / COAs for posted analytical records
China alone documented a 12.4% adult prevalence in 2024, translating into more than 140 million individuals who often remain undertreated
Risk Stratification & Contraindications Patient safety must guide the initiation of GLP-1 therapy, and therapy should be withheld if contraindications are present: Absolute Contraindications: Personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Cautionary History: Previous pancreatitis or gastroparesis 5
JAMA Netw Open 5(1):e2142078
Adults with a history of pancreatitis, gallbladder problems, or certain gastrointestinal conditions may need additional evaluation before treatment
US$ 21.84
US$ 23.20
US$ 21.22
US$ 27.62
US$ 28.75
